Breaking News Instant updates and real-time market news.

AAPL

Apple

$160.86

-0.64 (-0.40%)

, BBY

Best Buy

$56.79

0.83 (1.48%)

07:07
09/13/17
09/13
07:07
09/13/17
07:07

New iPhone sales unlikely 'substantially higher' than prior year, says Wedbush

WedBush analyst Michael Pachter notes that Apple's (AAPL) September 12 Special Event highlighted several planned introductions across its various product lines, including an iPhone with a new form factor and facial recognition technology. The analyst believes it is unlikely that sales will be substantially higher on this year's upgraded products versus the prior year given similar price points and release dates. However, the new wireless charging capability may drive incremental charger sales for Best Buy (BBY) and other retailers, he adds. Pachter also pointed out that GameStop (GME) is encouraging its customers to purchase one of the new iPhones by trading in an old phone or other electronic device at its stores.

AAPL

Apple

$160.86

-0.64 (-0.40%)

BBY

Best Buy

$56.79

0.83 (1.48%)

GME

GameStop

$19.53

0.33 (1.72%)

  • 19

    Sep

AAPL Apple
$160.86

-0.64 (-0.40%)

09/12/17
PIPR
09/12/17
NO CHANGE
Target $190
PIPR
Overweight
Apple 'met lofty expectations' for iPhone X upgrades, says Piper Jaffray
Piper Jaffray analyst Michael Olson said the features of Apple's iPhone X "generally met" the "lofty expectations" set by media reports prior to the company's product launch event today, pointing to its edge-to-edge OLED screen and 3D sensing as the key upgrades. Apple's prior commentary suggests this cycle will see a higher upgrade rate than previous iPhones, added Olson, who keeps an Overweight rating and $190 price target on Apple shares.
09/13/17
PIPR
09/13/17
NO CHANGE
Target $190
PIPR
Overweight
Apple's iPhone X lives up to lofty expectations, says Piper Jaffray
Piper Jaffray analyst Michael Olson believes Apple's iPhone X lived up to the loft expectations going into the unveiling event. Expectations were for Apple to deliver a device with a "relatively more robust set of upgraded features," and the company generally met these expectations, Olson tells investors in a research note. The analyst views the key upgrades as the change in form factor, namely the edge-to-edge OLED screen, and 3D sensing, which enables facial recognition. The only real disappointment around iPhone X, for some, may be timing, as the device will not ship until November 3, Olson writes. He reiterates an Overweight rating on Apple shares with a $190 price target. The stock closed yesterday down 68c to $160.82.
09/13/17
PIPR
09/13/17
NO CHANGE
Target $52
PIPR
Neutral
Dolby's annual Apple revenue could be up to $35M, says Piper Jaffray
Apple's (AAPL) iPhone X, iPhone 8, iPhone 8 Plus and Apple TV 4K will incorporate Dolby Vision (DLB), Piper Jaffray analyst Michael Olson tells investors in a research note. While the economics are unclear, assuming a royalty of 10c-15c per iPhone, revenue would fall between $20M-$30M annually for Dolby, Olson tells investors in a research note. Apple TV sales are likely 5M-8M units per year, potentially adding another $5M to revenue, the analyst estimates. He believes the longer term impact could be more material, however, depending on adoption of Vision on other devices. Olson upped his price target on Dolby shares to $52 from $49 and keeps a Neutral rating on the name.
09/13/17
JPMS
09/13/17
NO CHANGE
Target $176
JPMS
Overweight
Apple launch event in line with expectations, says JPMorgan
JPMorgan analyst Rod Hall views Apple's fall product launch event as largely in line with his expectations with the only exception being iPhone X availability toward the later end of what he expected. The face identification on the iPhone seemed to work very well, as did the new button free interface, Hall tells investors in a research note. He continues to believe Apple is likely to see better replacement demand into 2018 than consensus estimates imply. The analyst reiterates an Overweight rating on Apple with a $176 price target.
BBY Best Buy
$56.79

0.83 (1.48%)

09/05/17
LOOP
09/05/17
NO CHANGE
LOOP
Best Buy likely to gain market share, says Loop Capital
Loop Capital analyst Anthony Chukumba says the firm's recent survey indicates that "Best Buy's (BBY) prices were 0.6% more expensive than Amazon's 9AMZN) on average." The analyst reports that the gap is the smallest in the eight years the firm has tracked the company's' prices. As a result, he expects Best Buy to continue to gain market share. He keeps a $72 price target and a Buy rating on the stock.
08/30/17
UBSW
08/30/17
NO CHANGE
Target $60
UBSW
Neutral
Best Buy shares fairly valued at current levels, says UBS
UBS analyst Michael Lasser noted Best Buy shares sold off following Q2 results, which he believes was due to a combination of its healthy year-to-date move and a recalibration of expectations for it long-term earnings growth. The analyst noted top line strength as its Q2 results highlight, but he also said gross margin expansion is leveling off and its flow through could be more modest moving forward. Lasser believes shares are fairly valued at current levels, maintained his Neutral rating and lowered his price target to $60 from $62 on Best Buy shares.
08/30/17
RHCO
08/30/17
NO CHANGE
RHCO
Best Buy weakness overdone, says SunTrust
SunTrust analyst David Magee blames the weakness in Best Buy's stock following its Q2 beat and raise results on "profit taking." He calls the company's results "impressive" and says that the weakness is overdone, given what he calls the company's " recent history of driving share growth, while reducing" costs. The analyst remains upbeat on the company's long-term outlook and keeps a Buy rating on the shares.
08/29/17
RHCO
08/29/17
NO CHANGE
Target $70
RHCO
Buy
Best Buy pullback a buying opportunity, says SunTrust
SunTrust analyst David Magee is surprised in Best Buy share weakness today after reported a Q2 beat and Q3 guidance that was also better than expectations. Magee said some of the selling reflects the lack of "flow through" to profits, management comments regarding the acceleration in investments, and some profit taking. The analyst points out Best Buy is investing throughout the year to prepare for the seasonally important Q4, is developing its service business, and investment's should increase topline visibility in the intermediate term, partially funded by a new round of expense cuts. Magee recommends buying Best Buy on the pullback and reiterates his Buy rating and $70 price target.
GME GameStop
$19.53

0.33 (1.72%)

08/21/17
PIPR
08/21/17
NO CHANGE
PIPR
Overweight
Piper says video game industry could be '100% digital' in six years or less
Piper Jaffray analyst Michael Olson said comments from video game publishers and others in the industry lead him to the "best guess" that all video game purchases will be digital in about 6 years, or possibly sooner if the market spikes to 100% more quickly after reaching "critical mass" in a few years. Game publishers, including Activision Blizzard (ATVI), Electronic Arts (EA) and Take-Two (TTWO), will benefit from margin expansion as the industry approaches 100% digital, added Olson, who keeps Overweight ratings on all three game makers' shares. Another company often cited as being impacted by the industry's move to digital game downloads is retailer GameStop (GME).
08/23/17
BARD
08/23/17
NO CHANGE
Target $24
BARD
Outperform
GameStop should report in-line Q2 results, says Baird
Baird analyst Colin Sebastian said third party data shows stable selling trends for software sales and positive momentum for the Nintendo Switch, which points toward in-line Q2 results for GameStop (GME). Adding that overall industry selling trends appear little changed since May, Sebastian maintained his Outperform rating and $24 price target on GameStop shares.
08/25/17
RHCO
08/25/17
NO CHANGE
RHCO
GameStop Q2 EPS miss unimportant, says SunTrust
SunTrust analyst David Magee says he "would downplay" Gamestop's Q2 EPS miss, as he notes that Q2 is the company's weakest quarter from a seasonal perspective. The analyst thinks that the company will report "strong" 2H17 results, and he says that its cash flow is "strong," while its valuation is "low." He keeps a a Buy rating on the shares.
08/25/17
BARD
08/25/17
NO CHANGE
Target $21
BARD
Outperform
GameStop results inline but margin a bit light, says Baird
Baird analyst Colin Sebastian noted GameStop (GME) reported Q2 results inline with his expectations but said gross margins came in a bit light. He noted the results were generally driven by the Nintendo (NTDOY) Switch product. Looking ahead, the company should benefit from seasonal category strength, an ongoing hardware ramp, and improving pre-owned and tech brand trends, said Sebastian, who maintained his Outperform rating and $21 price target on GameStop shares.

TODAY'S FREE FLY STORIES

IOVA

Iovance Biotherapeutics

$7.15

-1.4 (-16.37%)

19:46
09/20/17
09/20
19:46
09/20/17
19:46
Syndicate
Iovance Biotherapeutics 7.69M share Secondary priced at $6.50 »

The deal priced at $6.50,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 21

    Sep

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

, CAB

Cabela's

$61.45

0.07 (0.11%)

18:28
09/20/17
09/20
18:28
09/20/17
18:28
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P SmallCap 600…

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

CAB

Cabela's

$61.45

0.07 (0.11%)

TPRE

Third Point Reinsurance

$14.40

-0.1 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDC

Western Digital

$86.37

-3.55 (-3.95%)

, TOSYY

Toshiba, also use TOSBF

$17.08

-0.29 (-1.67%)

18:26
09/20/17
09/20
18:26
09/20/17
18:26
Hot Stocks
Sandisk subsidiaries initiate new arbitration proceedings against Toshiba »

Western Digital (WDC)…

WDC

Western Digital

$86.37

-3.55 (-3.95%)

TOSYY

Toshiba, also use TOSBF

$17.08

-0.29 (-1.67%)

TOSBF

Toshiba, also use TOSYY

$2.87

-0.02 (-0.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOA

North American Energy

$4.10

-0.05 (-1.20%)

18:26
09/20/17
09/20
18:26
09/20/17
18:26
Hot Stocks
North American Energy awarded two earthworks contracts for $90M »

North American Energy has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISTR

Investar Holding

$23.15

0.15 (0.65%)

18:01
09/20/17
09/20
18:01
09/20/17
18:01
Hot Stocks
Investar Holding raises quarterly dividend to 3c from 2c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BECN

Beacon Roofing

$47.86

-0.63 (-1.30%)

17:56
09/20/17
09/20
17:56
09/20/17
17:56
Syndicate
Beacon Roofing 6.325M share Secondary priced at $47.50 »

BofA/Merrill, RBC Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

AMD

AMD

$13.74

0.62 (4.73%)

, AMPH

Amphastar

$15.64

-0.02 (-0.13%)

17:46
09/20/17
09/20
17:46
09/20/17
17:46
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: AMD (AMD), up 6%…

AMD

AMD

$13.74

0.62 (4.73%)

AMPH

Amphastar

$15.64

-0.02 (-0.13%)

GVP

GSE Systems

$2.80

0.05 (1.82%)

MLHR

Herman Miller

DPS

Dr Pepper Snapple

$91.68

-0.12 (-0.13%)

JUNO

Juno Therapeutics

$45.21

1.41 (3.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 28

    Sep

ABMD

Abiomed

$157.42

0.32 (0.20%)

17:36
09/20/17
09/20
17:36
09/20/17
17:36
Hot Stocks
Abiomed receives FDA PMA approval for Impella RP for right heart failure »

Abiomed has received FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSK

Oshkosh

$79.69

0.34 (0.43%)

17:35
09/20/17
09/20
17:35
09/20/17
17:35
Hot Stocks
Oshkosh awarded $466.7M government contract modification »

Oshkosh Defense, Oshkosh,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AET

Aetna

$155.03

-1.01 (-0.65%)

17:32
09/20/17
09/20
17:32
09/20/17
17:32
Hot Stocks
Aetna president Lynch sells $2.5M of company shares »

The president of health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRN

Blue Apron

$5.22

-0.29 (-5.26%)

17:25
09/20/17
09/20
17:25
09/20/17
17:25
Hot Stocks
Blue Apron jumps after meal kit competitor Plated acquired by Albertsons »

Earlier today, food…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$91.68

-0.12 (-0.13%)

17:22
09/20/17
09/20
17:22
09/20/17
17:22
Earnings
Dr Pepper Snapple cuts FY17 EPS view to $4.53-$4.63 from $4.56-$4.66 »

FY17 consensus $4.63. In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBI

Hanesbrands

$24.64

-0.07 (-0.28%)

17:22
09/20/17
09/20
17:22
09/20/17
17:22
Downgrade
Hanesbrands rating change at Nomura Instinet »

Hanesbrands downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPRE

Third Point Reinsurance

$14.40

-0.1 (-0.69%)

, SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

17:19
09/20/17
09/20
17:19
09/20/17
17:19
Hot Stocks
Breaking Hot Stocks news story on Third Point Reinsurance, Sanderson Farms »

Third Point Reinsurance…

TPRE

Third Point Reinsurance

$14.40

-0.1 (-0.69%)

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

, CAB

Cabela's

$61.45

0.07 (0.11%)

17:18
09/20/17
09/20
17:18
09/20/17
17:18
Hot Stocks
Sanderson Farms to replace Cabela's in S&P 400 at open on 9/26 »

Bass Pro Shops is…

SAFM

Sanderson Farms

$162.06

1.5 (0.93%)

CAB

Cabela's

$61.45

0.07 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IPCI

Intellipharmaceutics

17:14
09/20/17
09/20
17:14
09/20/17
17:14
Hot Stocks
Intellipharmaceutics receives Nasdaq non-compliance notice »

Intellipharmaceutics has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RWLK

ReWalk Robotics

17:13
09/20/17
09/20
17:13
09/20/17
17:13
Syndicate
Breaking Syndicate news story on ReWalk Robotics »

ReWalk Robotics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABM

ABM

$39.29

0.23 (0.59%)

17:11
09/20/17
09/20
17:11
09/20/17
17:11
Hot Stocks
Breaking Hot Stocks news story on ABM »

Thomas H. Lee Advisors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVTY

Invuity

$8.35

-0.15 (-1.76%)

17:07
09/20/17
09/20
17:07
09/20/17
17:07
Hot Stocks
Breaking Hot Stocks news story on Invuity »

Discovery Group raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Nov

USG

USG

$31.26

1.84 (6.25%)

, CBPX

Continental Building

$25.60

1.25 (5.13%)

17:04
09/20/17
09/20
17:04
09/20/17
17:04
Hot Stocks
Gypsum stocks jump after peer National Gypsum announces price increase »

Shares of companies…

USG

USG

$31.26

1.84 (6.25%)

CBPX

Continental Building

$25.60

1.25 (5.13%)

EXP

Eagle Materials

$105.07

2.9 (2.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

TRHC

Tabula Rasa HealthCare

$25.66

-0.38 (-1.46%)

16:46
09/20/17
09/20
16:46
09/20/17
16:46
Recommendations
Tabula Rasa HealthCare analyst commentary at Piper Jaffray »

Tabula Rasa HealthCare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

16:40
09/20/17
09/20
16:40
09/20/17
16:40
General news
Fed Leans into Wind on Balance Sheet: »

Fed Leans into Wind on…

TPIV

TapImmune

$3.08

-0.01 (-0.32%)

16:37
09/20/17
09/20
16:37
09/20/17
16:37
Syndicate
Breaking Syndicate news story on TapImmune »

TapImmune files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBSB

Meridian Bancorp

$18.15

0.1 (0.55%)

16:36
09/20/17
09/20
16:36
09/20/17
16:36
Hot Stocks
Meetinghouse receives shareholder approval for merger with Meridian Bancorp »

Meridian Bancorp, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRNY

Kearny Financial

$15.10

0.2 (1.34%)

16:34
09/20/17
09/20
16:34
09/20/17
16:34
Hot Stocks
Kearny Financial declares special cash dividend of 12c per share »

Kearny Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.